ACLX logo

Arcellx, Inc. (ACLX)

Profile

Full Name

Arcellx, Inc.

Ticker

NASDAQ: ACLX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 4, 2022

Indexes

Not included

Website

https://www.arcellx.com

Employees

163

Key Details

Price

$71.28(-0.68%)

Market cap

$3.95B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$107.94M(-2.16% YoY)

Annual EPS

-$2.00(-36.05% YoY)

PE ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $71.28
    ACLX price is $71.28

    30-Day Relative Volume

    0.89
    ACLX 30-day relative volume is 0.89

    Price Performance

    Price Most recent change

    -0.68%
    ACLX price was down -0.68% on Aug 22, 2025

    Price YTD change

    -7.05%
    ACLX price is down -7.05% since January 1st

    Price 1-year change

    +7.25%
    ACLX price is up +7.25% year-on-year

    Price 3-year change

    +293.16%
    ACLX price is up +293.16% over the past 3 years

    Price Range

    Price All-time high

    $107.37
    ACLX price is currently -33.61% below its historical high of $107.37

    Price 3-year low

    $15.63
    ACLX price is currently +356.05% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $3.95B
    ACLX market capitalization is $3.95 billion

    Market cap 3-year change

    +397.6%
    ACLX market capitalization is up +397.6% over the past 3 years

    Market cap All-time high

    $5.76B
    ACLX market capitalization is currently -31.38% below its historical high of $5.76 billion

    Market cap sector rank

    87.03%
    ACLX market capitalization is higher than 87.03% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.17%
    ACLX shares outstanding is up +3.17% year-on-year

    Shares Outstanding 3-Year Change

    +26.56%
    ACLX shares outstanding is up +26.56% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.21
    ACLX beta is 1.21

    200-day SMA

    $70.31
    ACLX price is currently +1.37% above its 200-day simple moving average

    50-day SMA

    $68.70
    ACLX price is currently +3.76% above its 50-day simple moving average

    RSI

    52.19
    ACLX 14-day relative strength index is 52.19

    Volume

    0.89
    ACLX 30-day relative volume is 0.89

    ATR

    $3.09
    ACLX average true range is $3.09

    10-day Historical Volatility

    38.82%
    ACLX 10-day historical volatility is 38.82%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $107.94M
    ACLX annual revenue is $107.94 million

    Revenue Analysts estimate

    $55.18M
    ACLX annual revenue is currently +95.62% higher than the consensus analysts' forecast

    Revenue 1-year change

    -2.16%
    ACLX annual revenue is down -2.16% year-on-year

    Revenue Sector rank

    68.95%
    ACLX annual revenue is higher than 68.95% of companies in Healthcare sector

    EPS

    EPS

    -$2.00
    ACLX annual earnings per share is -$2.00

    EPS Analysts estimate

    -$4.06
    ACLX annual earnings per share is currently -50.77% lower than the consensus analysts' forecast

    EPS 1-year change

    -36.05%
    ACLX annual earnings per share is down -36.05% year-on-year

    EPS Sector rank

    37.27%
    ACLX annual earnings per share is higher than 37.27% of companies in Healthcare sector

    Profit

    Gross profit

    $102.75M
    ACLX annual gross profit is $102.75 million

    Gross margin

    95.19%
    ACLX annual gross profit margin is 95.19%

    Operating profit

    -$137.57M
    ACLX annual operating income is -$137.57 million

    Operating margin

    -127.46%
    ACLX annual operating profit margin is -127.46%

    Net income

    -$107.35M
    ACLX annual net profit is -$107.35 million

    Net margin

    -99.46%
    ACLX annual net profit margin is -99.46%

    Expenses

    Total expenses

    $245.51M
    ACLX annual total expenses is $245.51 million

    Operating expenses

    $245.51M
    ACLX annual total operating expenses is $245.51 million

    Cost of goods sold

    $5.19M
    ACLX annual cost of goods sold is $5.19 million

    Selling, general & administrative expenses

    $88.41M
    ACLX annual SGA is $88.41 million

    Depreciation and amortization

    $5.19M
    ACLX annual depreciation & amortization is $5.19 million

    Interest expense

    $0.00
    ACLX annual interest expense is $0.00

    Income tax

    $2.07M
    ACLX annual income tax is $2.07 million

    EBIT & EBITDA

    EBIT

    -$104.25M
    ACLX annual earnings before interest & taxes is -$104.25 million

    EBITDA

    -$99.06M
    ACLX annual EBITDA is -$99.06 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $711.33M
    ACLX annual total assets is $711.33 million

    Non current assets

    $112.02M
    ACLX annual long term assets is $112.02 million

    Current assets

    $599.31M
    ACLX annual total current assets is $599.31 million

    Cash and cash equivalents

    $105.68M
    ACLX annual cash & cash equivalents is $105.68 million

    Accounts receivable

    -
    ACLX annual accounts receivable value is unknown

    Inventory

    $0.00
    ACLX annual inventory is $0.00

    Liabilities

    Total liabilities

    $256.54M
    ACLX annual total liabilities is $256.54 million

    Long term liabilities

    $131.13M
    ACLX annual total long term liabilities is $131.13 million

    Current liabilities

    $125.41M
    ACLX annual total current liabilities is $125.41 million

    Accounts payable

    $2.10M
    ACLX annual accounts payable is $2.10 million

    Debt

    Total debt

    $54.08M
    ACLX annual total debt is $54.08 million

    Total debt 1-year change

    -44.6%
    ACLX annual total debt is down -44.6% year-on-year

    Long term debt

    $46.54M
    ACLX annual long term debt is $46.54 million

    Short term debt

    $7.54M
    ACLX annual short term debt is $7.54 million

    Equity & Capital

    Shareholders equity

    $454.79M
    ACLX annual stockholders equity is $454.79 million

    Book value

    $454.79M
    ACLX annual book value is $454.79 million

    Retained earnings

    -$496.83M
    ACLX annual retained earnings is -$496.83 million

    Working capital

    $473.90M
    ACLX annual working capital is $473.90 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$83.47M
    ACLX annual cash flow from operations is -$83.47 million

    Cash from operations 1-year change

    -140.21%
    ACLX annual cash flow from operations is down -140.21% year-on-year

    Cash from investing

    -$183.04M
    ACLX annual cash flow from investing activities is -$183.04 million

    Cash from investing 1-year change

    -18.47%
    ACLX annual cash flow from investing activities is down -18.47% year-on-year

    Cash from financing

    -$24.09M
    ACLX annual cash flow from financing activities is -$24.09 million

    Cash from financing 1-year change

    -108.63%
    ACLX annual cash flow from financing activities is down -108.63% year-on-year

    CAPEX

    CAPEX

    $13.43M
    ACLX annual capital expenditures is $13.43 million

    CAPEX 1-year change

    -37.31%
    ACLX annual capital expenditures is down -37.31% year-on-year

    Free Cash Flow

    Free cash flow

    -$96.90M
    ACLX annual free cash flow is -$96.90 million

    Free cash flow 1-year change

    -152.06%
    ACLX annual free cash flow is down -152.06% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    95.19%
    ACLX annual gross profit margin is 95.19%

    Operating margin

    -127.46%
    ACLX annual operating profit margin is -127.46%

    Net margin

    -99.46%
    ACLX annual net profit margin is -99.46%

    ROA & ROE

    ROA

    -13.97%
    ACLX annual return on assets is -13.97%

    ROE

    -22.84%
    ACLX annual return on equity is -22.84%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ACLX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ACLX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    10.08
    ACLX price to book ratio is 10.08

    PB ratio Sector rank

    88.73%
    ACLX price to book ratio is higher than 88.73% of companies in Healthcare sector

    PS Ratio

    PS ratio

    69.38
    ACLX price to sales ratio is 69.38

    PS ratio Sector rank

    89.54%
    ACLX price to sales ratio is higher than 89.54% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $3.55B
    ACLX enterprise value is $3.55 billion

    Enterprise value Sector rank

    85.77%
    ACLX enterprise value is higher than 85.77% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -19.76
    ACLX EV/EBITDA is -19.76

    EV/EBITDA Sector rank

    7%
    ACLX EV/EBITDA is higher than 7% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.78
    ACLX annual current ratio is 4.78

    Quick ratio

    4.78
    ACLX annual quick ratio is 4.78

    Leverage

    Debt to equity

    0.12
    ACLX annual debt to equity ratio is 0.12

    Interest coverage ratio

    -
    ACLX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    2
    ACLX piotroski f-score is 2

    Altman Z-Score

    8.74
    ACLX altman z-score is 8.74

    Analyst ratings

    Recent major analysts updates

    Jul 31, 25 Scotiabank
    Sector Outperform
    Jun 17, 25 Citigroup
    Buy
    Jun 16, 25 HC Wainwright & Co.
    Buy
    May 9, 25 Scotiabank
    Sector Outperform
    Dec 10, 24 UBS
    Buy
    Dec 10, 24 Needham
    Buy
    Dec 10, 24 HC Wainwright & Co.
    Buy
    Dec 9, 24 Needham
    Buy
    Nov 12, 24 Truist Securities
    Buy
    Nov 8, 24 Piper Sandler
    Overweight

    Institutional Ownership

    Screeners with ACLX included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks with high beta
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    Best performing stocks last 3 years
    High Altman Z score stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Arcellx, Inc.?
    • Does Arcellx, Inc. pay dividends?
    • What sector is Arcellx, Inc. in?
    • What industry is Arcellx, Inc. in?
    • What country is Arcellx, Inc. based in?
    • When did Arcellx, Inc. go public?
    • Is Arcellx, Inc. in the S&P 500?
    • Is Arcellx, Inc. in the NASDAQ 100?
    • Is Arcellx, Inc. in the Dow Jones?
    • When was Arcellx, Inc.'s last earnings report?
    • When does Arcellx, Inc. report earnings?

    What is the ticker symbol for Arcellx, Inc.?

    The ticker symbol for Arcellx, Inc. is NASDAQ:ACLX

    Does Arcellx, Inc. pay dividends?

    No, Arcellx, Inc. does not pay dividends

    What sector is Arcellx, Inc. in?

    Arcellx, Inc. is in the Healthcare sector

    What industry is Arcellx, Inc. in?

    Arcellx, Inc. is in the Biotechnology industry

    What country is Arcellx, Inc. based in?

    Arcellx, Inc. is headquartered in United States

    When did Arcellx, Inc. go public?

    Arcellx, Inc.'s initial public offering (IPO) was on February 4, 2022

    Is Arcellx, Inc. in the S&P 500?

    No, Arcellx, Inc. is not included in the S&P 500 index

    Is Arcellx, Inc. in the NASDAQ 100?

    No, Arcellx, Inc. is not included in the NASDAQ 100 index

    Is Arcellx, Inc. in the Dow Jones?

    No, Arcellx, Inc. is not included in the Dow Jones index

    When was Arcellx, Inc.'s last earnings report?

    Arcellx, Inc.'s most recent earnings report was on May 8, 2025

    When does Arcellx, Inc. report earnings?

    The next expected earnings date for Arcellx, Inc. is November 6, 2025
    On this page